ATM and neoplasm: In our analysis here, we identified germline non-coding variants, including mirSNPs in DNA repair genes such as ATM and BRCA1, which directly align with research finding alternative, non tumor-tissue dependent biomarkers to predict TMB [27], supporting the concept that inherited genetic variation contributes to tumor biology and treatment response, by potentially shaping the molecular landscape in which somatic mutations arise.